4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-20-000251
Options or other derivatives
- Pres. Diagnostics & Genom acquired 39,644 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kelderman Kim · Pres. Diagnostics & Genom
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-05 | Grant or award : show line 1 in the form Restricted Stock Units | +2,015 | 2,015 | D |
| 2020-08-05 | Grant or award : show line 2 in the form Stock Options (Right to Buy) | +8,991 | 8,991 | D |
| 2020-08-05 | Grant or award : show line 3 in the form Stock Options (Right to Buy) | +11,988 | 11,988 | D |
| 2020-08-05 | Grant or award : show line 4 in the form Stock Options (Right to Buy) | +8,325 | 8,325 | D |
| 2020-08-05 | Grant or award : show line 5 in the form Stock Options (Right to Buy) | +8,325 | 8,325 | D |
Loading xslF345X03/edgar.xml…